In ME/CFS, the increased utilisation of glutamine/glutamate through both the GLUD1 and GOT2 routes has been suggested through the outcomes of metabolomic studies [3,4,6]. This evidence concerns the gene GOT2 and myalgic encephalomeyelitis/chronic fatigue syndrome.